Biosensors for Point-of-Care Diagnostics 2022-2032: Technology, Opportunities, Players and Forecasts

Point-of-care biosensors have been crucial in handling the COVID-19 pandemic, which has caused the market to more than double since 2019. In this report IDTechEx explores the drivers of the market's growth, key technologies enabling point-of-care testing, assesses emerging technologies bringing patient diagnosis ever closer to the point-of-care, and the opportunities and threats that these trends present.

Login or Register You are not logged in. For existing users, please login to learn more about this premium content. For new users, please register with idtechex.com or use the links below for more details about premium content from IDTechEx.

Subscription Benefits


A subscription from IDTechEx allows you to access our full body of research content on emerging technologies, including market, technology and company data, alongside direct engagement with our expert analysts.
Subscription content includes:
  • Market research reports
  • Forecasts
  • Premium articles
  • Company profiles
  • Industry digests
  • Webinars
  • Innovation maps
  • Event summaries and write-ups

Report Statistics

Slides
254
Forecasts to
2032